Chris Beardmore

Mr. Beardmore is an experienced and qualified executive with start-up, regulatory, project management and operational experience across the healthcare industry. He began his career in regulatory affairs, influenced by leading human subject and animal subject protection committees at large academic institutions. While at the University of Maryland at Baltimore (UMAB), the University of California at Los Angeles (UCLA) and the United States Army Medical Research Institute of Infectious Disease (USAMRIID) he worked to improve human subject protection systems, served as an advisory to streamline research processes, drafted policies and procedures and developed training and education programs to improve systems. This included work with all stakeholders on issues related to ethical and regulatory application of International Conference on Harmonization Guidelines for Good Clinical Practice. While with USAMRIID, Mr. Beardmore authored a position paper proposing innovative approaches to developing investigational bio-warfare protective products for force health protection. These experiences led Mr. Beardmore to recognize the serious need to improve systems and permit ethical research to be conducted more efficiently. In 2004 he took on the role of Chief Operating Officer and Co-Founder of Premiere Onocology, located in Santa Monica, CA, Scottsdale, AZ, and San Diego, CA; offering patients access to early phase oncology clinical trials in one of the first community treatment settings. In 2009, Mr. Beardmore secured financing and launched Translational Research Management, LLC. The company created a 120 site community oncology network to speed development of innovative products for cancer patients. The network was connected to thousands of ancillary support providers and conducted hundreds of cancer clinical trials for the biopharmaceutical industry. Mr. Beardmore is a frequent presenter on these issues, and was invited by the Institute of Medicine to participate in a workshop envisioning a transformed clinical trials enterprise in the United States.